CP1 cannpal animal therapeutics limited
Add to My Watchlist 0.00% ! 17.0¢

News: CP1 Cannpal Animal Therapeutics Secures Exclusive Global Rights For Certain Technology

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    06/01/20
    12:35
    Post #: 42243985

    Jan 6 (Reuters) - CannPal Animal Therapeutics Ltd (CP1) :

    • GOT EXCLUSIVE GLOBAL RIGHTS TO COMMERCIALISE MICROMAX MICROENCAPSULATION TECHNOLOGY BY CSIRO FOR ANIMAL THERAPEUTICS USE
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AII Becoming the largest conflict-free tungsten supplier in the world
right-arrow Created with Sketch.
FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
NEWS Ausgold set to commence extensive multi-rig drilling campaign at Katanning
right-arrow Created with Sketch.
NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.